17 November 2021

UK's HSA report Week 42


In the United Kingdom, their health authority publishes a weekly report with regards to the happenings of pharmaceutical products with respect to the current global health situation.

The British government has admitted the fact that once a person has been double jabbed, full natural immunity will never again be acquired.

As a result one will be reliant upon the pharmaceutical's product, in effect creating a customer for life.

After all what good are you to a corporation if you only purchase their product only once twice or even three times soon being the new requirement in the colony called Australia.

Paying attention to page 23 of the report, the U.K. Health Security Agency admitted that the "N antibody levels appear to be lower in people who acquire infection following two doses of 'vaccination'"

It goes on to explain that this antibody drop is basically permanent.

What does this mean?

We know the vaccines do not stop infection or transmission of the virus (in fact, the report shows elsewhere that vaccinated adults are now being infected at much HIGHER rated than the unvaccinated).

What the British are saying is they are now finding the vaccine interferes with your body's innate ability after infection to produce antibodies against not just the spike protein but other pieces of the virus.

Specifically, vaccinated people do not seem to be producing antibodies to the nucleocapsid protein, the shell of virus, which are a crucial part of the response in unvaccinated people.

In the long term, people who take the vaccine will be far more vulnerable to any mutations in the spike protein that will come along, even if they have already been infected and recovered one, or more.

The unvaccinated, meanwhile, will produce lasting if not permanent immunity to all strains of the alleged virus after being infected with it naturally even just once.

See page 23:


See page 24:

See entire document within the link:

https://drive.google.com/file/d/1lYKT1bL_xEFIhI3IXM4IOcPsCselM6mm/view?usp=sharing

No comments: